Cargando…
Characterization of age-related immune features after autologous NK cell infusion: Protocol for an open-label and randomized controlled trial
BACKGROUND: Aging is usually accompanied by functional declines of the immune system, especially in T-cell responses. However, little is known about ways to alleviate this. METHODS: Here, 37 middle-aged healthy participants were recruited, among which 32 were intravenously administrated with expande...
Autores principales: | Tang, Xiaofeng, Deng, Biaolong, Zang, Aiping, He, Xiaowen, Zhou, Ye, Wang, Daimeng, Li, Dan, Dai, Xueyu, Chen, Jieqiong, Zhang, Xuhua, Liu, Ye, Xu, Yonghua, Chen, Jingjing, Zheng, Weijie, Zhang, Luding, Gao, Constance, Yang, Huanfeng, Li, Bin, Wang, Xueqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562930/ https://www.ncbi.nlm.nih.gov/pubmed/36248873 http://dx.doi.org/10.3389/fimmu.2022.940577 |
Ejemplares similares
-
Gallic acid induces T-helper-1-like T(reg) cells and strengthens immune checkpoint blockade efficacy
por: Deng, Biaolong, et al.
Publicado: (2022) -
Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8(+)T cells
por: Yang, Biaolong, et al.
Publicado: (2022) -
The application of autologous cancer immunotherapies in the age of memory-NK cells
por: Lizana-Vasquez, Gaby D., et al.
Publicado: (2023) -
Effect of autologous NK cell immunotherapy on advanced lung adenocarcinoma with EGFR mutations
por: Hong, Guodai, et al.
Publicado: (2019) -
NK cell-based autologous immune enhancement therapy (AIET) for cancer
por: Terunuma, H, et al.
Publicado: (2013)